A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
10/2002
10/24/2002	DE10113604A1 Verfahren zur Spaltung des humanen Wachstumshormons GH A process for cleavage of human growth hormone GH
10/24/2002	CA2444932A1 Aromatase inhibition to enhance assisted reproduction
10/24/2002	CA2444632A1 Vascular endothelial growth factor 2
10/24/2002	CA2444465A1 2,1-oxazoline and 1,2-pyrazoline-based inhibitors of dipeptidyl peptidase iv and method
10/24/2002	CA2444247A1 Inhibitors of integrin .alpha.v.beta.6
10/24/2002	CA2444164A1 Pufa polyketide synthase systems and uses thereof
10/24/2002	CA2443805A1 Novel tricyclic hydroxy carboxamides and derivatives thereof tocolytic oxytocin receptor antagonists
10/24/2002	CA2443699A1 Phenyl heterocyclyl ether
10/24/2002	CA2443639A1 Compositions containing imidazotriazinone for nasal application
10/24/2002	CA2443568A1 Novel pyridine- and cyclohexenyl-comprising pyrrolobenzodiazepi ne-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443567A1 Novel tricyclic pyridyl benzazepine carboxamides and derivatives thereofas tocolytic oxytocin receptor antagonists
10/24/2002	CA2443566A1 Novel 10-cyclohexenyl-phenyl pyrrolobenzodiazepine-3-carboxamides and derivatives thereof; tocolytic oxytocin receptor antagonists
10/24/2002	CA2443565A1 Novel cyclohexenyl phenyl diazepines vasopressin and oxytocin receptor modulators
10/24/2002	CA2443564A1 Novel hydroxy cyclohexenyl phenyl carboxamides tocolytic oxytocin receptor antagonists
10/24/2002	CA2443559A1 Compositions containing cgmp pde inhibitors and local anaesthetic agents for nasal application
10/24/2002	CA2443490A1 Tricyclic diazepines as tocolytic oxytocin receptor antagonists
10/24/2002	CA2443471A1 An effervescent solid composition of matter
10/24/2002	CA2443244A1 Enzymes
10/24/2002	CA2441699A1 Methods and compositions for stable transgenic plant pharmaceuticals and their use as contraceptives
10/24/2002	CA2438107A1 G-protein coupled receptor molecules and uses thereof
10/23/2002	EP1250432A2 Nuclear hormone receptors
10/23/2002	EP1250429A2 Human sperm specific lysozyme-like proteins
10/23/2002	EP1250338A1 Pyrazino-pyridazine derivatives as ligands for gaba receptors
10/23/2002	EP1250325A1 Phenanthridine-n-oxides
10/23/2002	EP1250148A1 Use of fsh for treating infertility
10/23/2002	EP1250142A1 Multivalent electron active compositions and methods of making and using same
10/23/2002	EP1250138A1 Fulvestrant formulation
10/23/2002	EP0626845B1 Improved amino acid solutions for treatment of peritoneal dialysis patients
10/23/2002	CN1376160A Novel macrolide antibiotics
10/23/2002	CN1376146A Solid-state form of celecoxil having enhanced bioavailability
10/23/2002	CN1376070A Method for the therapeutic management of extrauterine prolifieration of endometrical tissue, chronic pelvic pain and fallopian tube obstruction
10/23/2002	CN1376067A Conditioned cell culture medium compositions and method of use
10/23/2002	CN1376043A Drug delivery of phase changing formulation
10/23/2002	CN1376036A Metal-containing compositions, preparations and uses
10/23/2002	CN1375494A Iso-indolo-indolone compound, their preparation methods and drug compositions comprising the same
10/23/2002	CN1375322A Mixed Chinese medicine prepn. for treating natural miscrarriage
10/23/2002	CN1375292A Mixed snuff prepn. for reducing side effect of Apomorphinum
10/23/2002	CN1092978C Oral liquid for curing ganopathy
10/23/2002	CN1092966C Lactobacillus ointment for treatment of vaginal diseases and preparation method therefor
10/22/2002	US6469064 Treating depression and affective disorders, such as obsessive compulsive disorder in a patient by administering to the patient an effective amount of flavoxamine ester derivatives
10/22/2002	US6469047 Tyrosine derivatives
10/22/2002	US6469037 Prophylactic or therapeutic drug for renal diseases
10/22/2002	US6469016 Treatment of female sexual dysfunction using phosphodiesterase inhibitors
10/22/2002	US6469012 Pyrazolopyrimidinones for the treatment of impotence
10/22/2002	US6469007 P-substituted-n-(2-(4-(2,3-dihydro-benzo(1,4)dioxin-5-yl) -piperazin-1-yl)-propyl)-n-pyridin-2-yl-benzamide,
10/22/2002	US6468989 Gel compositions containing metronidazole
10/22/2002	US6468756 Methods of identifying compounds that bind to SNORF25 receptors
10/22/2002	US6468526 For therapy of vaginal and gastrointestinal infections
10/22/2002	CA2106954C Dry starch-iodine pharmaceutical formulations
10/17/2002	WO2002082091A2 Method for identification of proteins from intracellular bacteria
10/17/2002	WO2002082077A2 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	WO2002081728A2 Quinoline inhibitors of hyak1 and hyak3 kinases
10/17/2002	WO2002081665A2 Implantation serine proteinases
10/17/2002	WO2002081636A2 Protein modification and maintenance molecules
10/17/2002	WO2002081521A2 Osteoprotegerin in milk
10/17/2002	WO2002081499A2 Somatostatin agonists
10/17/2002	WO2002081430A2 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	WO2002080966A2 Method for producing a vaccine containing autologous antibodies
10/17/2002	WO2002080935A1 Combination therapy comprising glucose reabsorption inhibitors and retinoid-x receptor modulators
10/17/2002	WO2002080926A1 Pyrazolopyrimidines as therapeutic agents
10/17/2002	WO2002080909A1 Utilization of pyrazoline derivatives in the preparation of a medicament for the prevention and/or treatment of proliferative cell diseases
10/17/2002	WO2002080900A1 Method for improving the well-being of poultry by in-ovo injection of carnitine
10/17/2002	WO2002080896A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors
10/17/2002	WO2002080887A2 Timed pulse release composition
10/17/2002	WO2002080851A2 Chimeric vaccines
10/17/2002	WO2002080754A2 Methods for using annexin for detecting cell death in vivo and treating associated conditions
10/17/2002	WO2002057261A3 Diaminothiazoles and their use as inhibitors of cyclin-dependent kinase
10/17/2002	WO2002041894A3 Selective dopamine d4 receptor agonists for treating sexual dysfunction
10/17/2002	WO2002040700A3 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
10/17/2002	WO2002034726A3 Pyrimidine-2,4,6-trione metalloproteinase inhibitors
10/17/2002	WO2002015920A3 Treatment of hyperproliferative diseases
10/17/2002	WO2001098354A3 Human receptors
10/17/2002	WO2001041760A8 Cyclooxygenase-2 inhibitor compositions having rapid onset of therapeutic effect
10/17/2002	US20020151695 Transforming growth factor-beta-related molecules and uses thereof
10/17/2002	US20020151554 Cyclin-dependent kinase inhibitors such as (4-Amino-2-((4-(4-methyl-1-piperazinyl)phenyl)amino)-5-thiazolyl) (2,3-dihydro-1,4-benzodioxin-6-yl)methanone for treatment of breast, lung, colon, and prostate cancer/tumors
10/17/2002	US20020151531 Administering to a female of child bearing age over a period of 28 consecutive days a first phase of from 18 to 21 daily dosage units of a progestational agent, and a second phase of from 1 to 7 daily dosage units of an antiprogestin agent
10/17/2002	US20020151530 Administering to a woman, undergoing estrogen replacement therapy for treating homonal deficiences, continuously and uninterruptedly, a therapeutic effective amount of both estrogen and a non-aromatizing androgen in daily dosage
10/17/2002	US20020151494 Novel amino acid sequences for human semaphorin-like polypeptides
10/17/2002	US20020151488 G-CSF analog compositions and methods
10/17/2002	US20020151485 Methods and compositions for modulating fertility
10/17/2002	US20020151483 C3b/C4b complement receptor-like molecules and uses thereof
10/17/2002	US20020151480 Identifying a compound to treat a cardiovascular disease, e.g., atherosclerosis, characterized by aberrant 10218 nucleic acid activity or expression; detecting the presence of a nucleic acid in the sample that hybridizes to the probe
10/17/2002	US20020151475 Compounds and methods for modulating cell adhesion
10/17/2002	US20020151015 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof
10/17/2002	US20020150980 Nucleotide sequences coding protein for use in the treatment of asthma, parkinson's, heart, hypotension, osteporosis and urogenital disorders
10/17/2002	DE10118550A1 New 3-ethanoylamino-3-phenyl-propionic acid derivatives, are integrin agonists or antagonists useful e.g. for treating angiogenic, cardiovascular, inflammatory, osteolytic or tumor diseases or infections
10/17/2002	DE10118306A1 Composition for intranasal administration of imidazo-triazinone derivative cGMP PDE inhibitor for treatment of erectile dysfunction, also containing local anesthetic to prevent nasal blockage and improve absorption
10/17/2002	DE10118305A1 Composition for intranasal administration of cGMP PDE inhibitor for treatment of erectile dysfunction, also containing local anesthetic to prevent nasal blockage and improve absorption
10/17/2002	CA2446462A1 Chimeric vaccines
10/17/2002	CA2443813A1 Method for identification of proteins from intracellular bacteria
10/17/2002	CA2443334A1 Protein modification and maintenance molecules
10/17/2002	CA2443293A1 Production of polyclonal monospecific antibodies against upar variants del4, del5 and del4+5, and the use thereof for diagnostic and therapeutical purposes
10/17/2002	CA2443099A1 Uses of benzylideneamino guanidines as ligands to the melanocortiin receptors
10/17/2002	CA2443085A1 Somatostatin agonists
10/17/2002	CA2443057A1 Novel benzylideneamino guanidines and their uses as ligands to the melanocortin receptors
10/17/2002	CA2442817A1 Implantation serine proteinases
10/17/2002	CA2442739A1 Novel antibodies that bind to antigenic polypeptides, nucleic acids encoding the antigens, and methods of use
10/17/2002	CA2442382A1 Methods for using annexin for detecting cell death in vivo and treating associated conditions
10/17/2002	CA2441499A1 Method for producing a vaccine
10/17/2002	CA2440724A1 Pyrazolopyrimidines as therapeutic agents

1 ... 386 387 388 389 390 391 392 393 394 395 396 397 398 399 400 401 402 403 404 405 406 ... 557